TRU.NYSETransunion

10-Q/A: TransUnion Restates Q3 2023 Financials Due to $81 Million Goodwill Overstatement

Sentiment:

Quarterly Report Amendment


TransUnion has amended its Q3 2023 report to correct an $81 million overstatement of a non-cash goodwill impairment, primarily due to a computational error in foreign currency translation.

Worse than expectedThe company's net income decreased significantly from a profit of $79.2 million in Q3 2022 to a loss of $318.8 million in Q3 2023.The company recorded a $414 million goodwill impairment charge, which negatively impacted the results.The company's adjusted net income and adjusted diluted earnings per share also decreased year-over-year.

Summary

  • TransUnion has restated its financial statements for the three and nine months ended September 30, 2023, due to a material misstatement.
  • The error involved an $81 million overstatement of a non-cash goodwill impairment related to the United Kingdom reporting unit.
  • This overstatement was primarily caused by a $69.3 million computational error in the manual translation of U.S. Dollar equivalent revenue and a $11.7 million foreign currency translation adjustment.
  • The company has identified a material weakness in its internal control over financial reporting and that its disclosure controls and procedures were ineffective as of September 30, 2023.
  • The restatement has impacted the consolidated balance sheet, statements of income, comprehensive income, cash flows, and stockholders equity.
  • The company's Q3 2023 revenue was $968.7 million, up from $938.2 million in Q3 2022.
  • The company reported a net loss of $318.8 million for Q3 2023, compared to a net income of $79.2 million in Q3 2022.
  • For the nine months ended September 30, 2023, the company reported a net loss of $212.2 million, compared to a net income of $223.0 million in the same period of 2022.

Sentiment

Score: 3

Explanation: The document reveals significant negative financial impacts due to a material misstatement and goodwill impairment, along with a material weakness in internal controls. While there are some positive aspects, the overall tone is negative from an investment perspective.

Positives

  • Revenue increased by 3.2% in Q3 2023 compared to Q3 2022, reaching $968.7 million.
  • The International segment saw revenue growth, driven by higher local currency revenue in most regions.
  • The company has taken steps to address the identified material weakness in internal controls.

Negatives

  • The company reported a net loss of $318.8 million for Q3 2023, a significant decrease from the net income of $79.2 million in Q3 2022.
  • A material weakness in internal control over financial reporting was identified.
  • Disclosure controls and procedures were deemed ineffective as of September 30, 2023.
  • The company recorded a $414 million goodwill impairment in Q3 2023.
  • The company's effective tax rate was (7.6)% for Q3 2023, lower than the 21% U.S. federal corporate statutory rate due to the non-deductible goodwill impairment.

Risks

  • The company's internal control over financial reporting was deemed ineffective due to a material weakness.
  • The company's disclosure controls and procedures were also deemed ineffective.
  • The company's future financial results could be negatively impacted by the identified material weakness.
  • The company's goodwill and intangible assets are subject to impairment risk.
  • Unfavorable macroeconomic conditions, particularly in the UK, could lead to further impairments.
  • The company is subject to various legal and regulatory proceedings, which could result in adverse outcomes.

Future Outlook

The company expects to recognize a gain of approximately $119.4 million as a reduction to interest expense due to the expectation that the variable rate that they receive will exceed the fixed rates of interest over the next twelve months. The company also expects to continue to pay a quarterly dividend, subject to approval by the board.

Management Comments

  • Management now believes the U.K. recovery will take longer, and will be at a slower pace, than previously expected.
  • Management believes the assumptions used in the quantitative analysis are reasonable and consistent with assumptions that would be used by other marketplace participants.

Industry Context

The document highlights the impact of macroeconomic conditions, such as inflation and rising interest rates, on the company's business, which is consistent with broader industry trends. The company's performance is also affected by the demand for consumer loans and auto loans, which are sensitive to interest rate changes.

Comparison to Industry Standards

  • The goodwill impairment charge of $414 million is a significant event and is not typical for companies in the credit reporting industry, suggesting a specific issue with the UK reporting unit.
  • The company's revenue growth of 3.2% in Q3 2023 is modest compared to some high-growth technology companies, but is in line with other established players in the data and analytics sector.
  • The company's adjusted EBITDA margin of 36.8% is within the range of other established data and analytics companies, but the decrease in margin for the nine-month period is a concern.
  • The company's leverage ratio of 3.7 is within the range of other companies in the sector, but the company's ability to service its debt is dependent on its ability to generate cash flow.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
internal_control_weaknessA material weakness in internal control over financial reporting was identified related to the interim goodwill impairment test.2023-09-30The material weakness resulted in a restatement of the financial statements and could lead to future misstatements.
disclosure_controlsDisclosure controls and procedures were deemed ineffective as of September 30, 2023.2023-09-30The ineffectiveness of disclosure controls could lead to inaccurate or untimely financial reporting.

Legal Proceedings

  • The company is in active litigation with the CFPB related to marketing practices and compliance with a prior consent order.
  • The company reached a settlement with the CFPB and FTC regarding its tenant and employment screening business, agreeing to pay $11 million in redress and $4 million in civil money penalties.
  • The company reached a settlement with the CFPB regarding security freezes, agreeing to pay $3 million in redress and $5 million in civil money penalties.
  • The company is cooperating with a DOJ investigation related to Argus' use of certain data collected under government contracts.

Stakeholder Impact

  • Shareholders will be negatively impacted by the restatement and the goodwill impairment.
  • Employees may be affected by the company's cost-cutting measures.
  • Customers may be impacted by changes in the company's services and pricing.
  • Creditors may be concerned about the company's increased debt and reduced profitability.

Next Steps

  • The company is developing a remediation plan to address the material weakness in internal control over financial reporting.
  • The company will continue to monitor its liquidity position and may elect to raise funds through debt or equity financing in the future.
  • The company will continue to monitor the macroeconomic conditions and their impact on the business.

Key Dates

DateDescription
2021-12-17Completed the sale of the Healthcare business.
2022-04-08Completed the acquisition of Verisk Financial Services (VF).
2022-12-30Sold the non-core businesses from the VF acquisition.
2023-09-30End of the quarterly period for which financial statements were restated.
2023-10-05Reached a settlement with the CFPB and FTC regarding the tenant and employment screening business.
2023-10-10Reached a settlement with the CFPB regarding security freezes.
2023-10-24Original Q3 2023 10-Q was filed with the SEC.
2024-01-06Audit Committee concluded that the Q3 2023 Interim Financial Statements were materially misstated.
2024-01-08Current Report on Form 8-K filed with the SEC disclosing the material misstatement.
2024-01-11Amendment No. 1 to Quarterly Report on Form 10-Q/A filed with the SEC.

Keywords

restatement, goodwill impairment, internal control, financial reporting, disclosure controls, material weakness, revenue, net loss, financial statements, UK reporting unit, foreign currency translation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.